Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05268055 |
Other study ID # |
H00021294 |
Secondary ID |
5R21DC019216 |
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
May 3, 2023 |
Est. completion date |
October 1, 2023 |
Study information
Verified date |
October 2023 |
Source |
University of Massachusetts, Worcester |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The goal of this research is to create a training film for hearing healthcare providers to
teach them how to competently and sensitively interact with Deaf patients. In Year 1, focus
groups will be facilitated to elicit feedback that will inform video production of the
training film. In Year 2, film production will take place, as well as an RCT to test the
feasibility and preliminary efficacy of the new training intervetion.
Description:
The U.S. Deaf community - a minority group of more than 500,000 people who use American Sign
Language (ASL) - is one of the most understudied and underserved populations within our
nation's healthcare system. Reasons for this underrepresentation include lack of language
access in healthcare and research settings, as well as communal feelings of mistrust toward
the medical community. For example, healthcare providers and clinical researchers follow a
medical model to "cure" or "fix" deafness, whereas most Deaf people do not want to be fixed,
but rather to be respected as a cultural and linguistic minority group.
To begin to rectify this mistrust and underrepresentation, the informed consent process has
been suggested as a key area of intervention. From 2016 - 2018, our team produced a film to
train research personnel to effectively interact with Deaf research participants during the
informed consent process. The intervention was designed through a two-year collaboration with
the local Deaf community - community forums, focus groups, and an intervention development
team inclusive of Deaf researchers, filmmakers, and laypeople.
In 2022, our team conducted a second series of focus groups with key stakeholders to refine,
expand, and tailor a new version of the Sign Here training film for healthcare providers.
Filmmaking is currently underway. In April 2023, we will launch a randomized controlled trial
to test the feasibility, acceptability, and preliminary efficacy of the new training
intervention. Eighty healthcare providers, medical students, and nursing students will be
randomized to receive (1) the Sign Here training film or (2) an "intervention as usual"
condition (i.e., standard written guidance on how to communicate with Deaf patients in
healthcare settings). Primary outcomes are provider cultural competence, communication skill,
and ability to build trust, which will be tested via virtual simulation with a Deaf
standardized patient.
Results will potentially validate a product of immediate value - a highly-accessible,
easy-to-disseminate training film to promote the inclusion of Deaf people in our nation's
healthcare system. Results will also inform the design of a large, multi-institution study to
explore the real-world scalability of the Sign Here training film in medical schools across
the U.S.